Beyond BMI : Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria
Diabetes, Obesity and Metabolism · 2026-08 · 28 (8) · 6699-6712
DOI: 10.1111/dom.70846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 11.05.2026. Verfasst von Ru-Tao Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Obesity, Body Mass Index, Fatty Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Shanghai Pudong New Area Health Commission, Shanghai Oriental Talent Top-notch Program, Special Funding Program for Overseas Visiting Graduate Students of Shanghai University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Aims
To examine obesity prevalence and reclassification under the new Lancet Commission on Obesity criteria among adults aged 18–59 years with metabolic dysfunction–associated steatotic liver disease (MASLD), including BMI‐defined lean‐MASLD.
Methods
We analysed NHANES 2017–2018 data from adults aged 18–59 years with MASLD, the age range available for dual‐energy X‐ray absorptiometry (DEXA) in adults of NHANES. Obesity was defined using the new Lancet Commission criteria and the traditional BMI‐based criteria. The new criteria incorporated waist circumference, waist‐to‐hip ratio, waist‐to‐height ratio and body fat percentage measured by DEXA. Individuals were classified as having obesity if any of the following conditions were met: (1) BMI ≥ 40 kg/m 2 ; (2) elevated BMI in combination with at least one elevated anthropometric measure; (3) at least two elevated anthropometric measures, irrespective of BMI; (4) excess body fat assessed by DEXA. Elevated BMI and traditional obesity was defined as BMI ≥ 27.5 kg/m 2 for Asian and BMI ≥ 30 kg/m 2 for other ethnicities.
Results
(1) The new criteria increased the estimated prevalence of obesity among patients with MASLD from 66.8% (95% CI, 60.6%–72.4%) to 98.3% (95% CI, 97.3%–99.0%). (2) Among MASLD patients classified as non‐obese by traditional criteria, 94.9% were reclassified as obese under the new criteria. (3) Among BMI‐defined lean‐MASLD, 84.2% met the new obesity criteria.
Conclusion
Among adults aged 18–59 years with MASLD, the new obesity criteria increased the estimated prevalence of obesity to 98.3%. Moreover, 94.9% of individuals considered non‐obese by traditional BMI criteria and 84.2% of those with BMI‐defined lean MASLD met the new obesity criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Clinical Laboratory, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, Shanghai, China.
- Institute of Interdisciplinary Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Clinical Research Center, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Ru-Tao Lin, Qin Feng
Förderung
- Shanghai Pudong New Area Health Commission
- Shanghai Oriental Talent Top-notch Program
- Special Funding Program for Overseas Visiting Graduate Students of Shanghai University of Traditional Chinese Medicine
- National Science Foundation of China
- National Administration of Traditional Chinese Medicine
- National Natural Science Foundation of China
Zitieren
APA
Lin, R. T., Zeng, R. Q., Shen, X. T., Sun, Q. M., Xin, X., Chen, J. M., Hu, Y. Y., & Feng, Q. (2026). Beyond BMI : Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria. Diabetes, Obesity and Metabolism, 28(8), 6699-6712. https://doi.org/10.1111/dom.70846
Vancouver
Lin RT, Zeng RQ, Shen XT, Sun QM, Xin X, Chen JM, et al. Beyond BMI : Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria. Diabetes, Obesity and Metabolism. 2026;28(8):6699-6712. doi:10.1111/dom.70846
BibTeX
@article{Lin2026,
author = {Lin, Ru-Tao and Zeng, Ren-Qiang and Shen, Xu-Ting and Sun, Qin-Mei and Xin, Xin and Chen, Jia-Mei and Hu, Yi-Yang and Feng, Qin},
title = {Beyond BMI : Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {8},
pages = {6699--6712},
doi = {10.1111/dom.70846}
}
EUVIMED